Literature DB >> 15893715

Koebner phenomenon in lupus erythematosus with special consideration of clinical findings.

Hiroaki Ueki1.   

Abstract

The isomorphic response of Koebner can be observed not only in psoriasis, but also in other diseases, such as lichen planus and some systemic diseases including LE (lupus erythematosus) or sarcoidosis. Several clinical findings in LE skin were presented and discussed in this review. The mutually-interactive-, negative-, and internal-Koebner phenomena were introduced and discussed with some speculative views. Many forms of environmental stress on the skin were reported as provocating factors of the Koebner phenomenon, including trauma, scratching, UV-exposure, and various types of dermatitis. Clinical observations of the nature, localization, and movement of lesions should be carefully made. The pathophysiology of the Koebner phenomenon may be classified into two steps. A first non-specific inflammatory step and a second disease-specific step. The inflammatory products released from the first step would be targeted in the second step. In the first step, there could be many substances including cytokines, stress proteins, adhesion molecules, or autoantigens translocated from intra-cellular areas. In the second step after latent periods, there may be disease-specific reactions, including ones by T-cells, B-cells, autoantibodies, and immune deposits, under the restriction of genetic backgrounds. The Koebner phenomenon may prove useful in understanding the pathophysiology of diseases of unknown origin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15893715     DOI: 10.1016/j.autrev.2004.11.007

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  15 in total

1.  Koebner's phenomenon as a rare mechanism of acute myeloid leukemia dissemination: report of two cases with a brief overview.

Authors:  Andrea Tendas; Pasquale Niscola; Stefano Fratoni; Luca Cupelli; Luciana Morino; Benedetta Neri; Micaela Ales; Laura Scaramucci; Marco Giovannini; Rosanna Barbati; Teresa Dentamaro; Paolo de Fabritiis
Journal:  Support Care Cancer       Date:  2010-09-30       Impact factor: 3.603

2.  [Cutaneous lupus erythematosus. Part 1: clinical manifestations and classification].

Authors:  A Kuhn; K Gensch; S Ständer; G Bonsmann
Journal:  Hautarzt       Date:  2006-03       Impact factor: 0.751

3.  [Light induced subacute cutaneous lupus erythematodes: diagnosis and management].

Authors:  M Haust; S Meller; D Bruch-Gerharz; B Homey
Journal:  Hautarzt       Date:  2007-10       Impact factor: 0.751

4.  Discoid lupus erythematosus: when a superficial injury is a red herring of underlying disease.

Authors:  Emily Senderey; Shamik Patel
Journal:  BMJ Case Rep       Date:  2017-10-15

Review 5.  Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.

Authors:  Yoshinao Muro; Kazumitsu Sugiura; Masashi Akiyama
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

6.  Psoriasis in systemic lupus erythematosus: a single-center experience.

Authors:  Konstantinos Tselios; Kristy Su-Ying Yap; Rattapol Pakchotanon; Ari Polachek; Jiandong Su; Murray B Urowitz; Dafna D Gladman
Journal:  Clin Rheumatol       Date:  2017-02-06       Impact factor: 2.980

Review 7.  Koebner's phenomenon in systemic lupus erythematosus.

Authors:  Barbara S Longhi; Maraisa Centeville; Roberto Marini; Simone Appenzeller
Journal:  Rheumatol Int       Date:  2011-03-25       Impact factor: 2.631

8.  [Cutaneous lupus erythematosus. Part 2: diagnostics and therapy].

Authors:  A Kuhn; K Gensch; S Ständer; G Bonsmann
Journal:  Hautarzt       Date:  2006-04       Impact factor: 0.751

9.  Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9.

Authors:  Cristiana Guiducci; Claudio Tripodo; Mei Gong; Sabina Sangaletti; Mario P Colombo; Robert L Coffman; Franck J Barrat
Journal:  J Exp Med       Date:  2010-11-29       Impact factor: 14.307

10.  Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus.

Authors:  Michael Sticherling
Journal:  Biologics       Date:  2011-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.